Table 3 Logistic regression model for assessing the effect of TB co-infection on immunologic failure, December 2011–August 2012, JUSH, Ethiopia
Logistic regression | Follow up time in months | |||||||
|---|---|---|---|---|---|---|---|---|
At 6 months of ART initiation | At 12 months of ART initiation | |||||||
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
OR (95 % CI) | P | AOR (95 % CI) | P | AOR (95 % CI) | P | AOR (95 % CI) | P | |
Variables | ||||||||
TB status | ||||||||
Absent | Reference | – | Reference | Reference | – | Reference | – | |
Present | 1.10 (0.59–1.69) | 0.985 | 0.96 (0.56–3.46) | 0.540 | 1.06 (0.58–1.93) | 0.839 | 1.04 (0.46–1.89) | 0.740 |
Age in years | 0.98 (0.96–1.01) | 0.100 | 0.76 (0.75–2.23) | 0.062 | 0.97 (0.95–0.99) | 0.012 | 0.98 (0.95–0.99) | 0.049 |
Weight in kg | 0.97 (0.95–0.99) | 0.011 | 0.98 (0.95–0.99) | 0.030 | 0.99 (0.96–1.01) | 0.218 | 0.37 (0.089–3.45) | 0.347 |
CD4 count category in cells/mm3 | ||||||||
<50 | 14.2 (1.52–16.42) | 0.020 | 12.0 (1.26–13.79) | 0.031 | 24.67 (1.25–32.53) | 0.005 | 19.97 (2.09–34.52) | 0.009 |
50–100 | 10.4 (1.45–14.53) | 0.003 | 9.8 (1.26–12.80) | 0.044 | 13.43 (1.52–18.63) | 0.019 | 12.28 (1.37–14.09) | 0.025 |
101–200 | 9.6 (1.09–13.87) | 0.041 | 9.50 (1.08–14.39) | 0.043 | 15.52 (1.82–26.48) | 0.012 | 14.39 (1.66–23.49) | 0.015 |
>200 | Reference | – | Reference | – | Reference | – | Reference | – |